News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

bioMerieux, Inc. Buys Microbiological Analysis Firm AES for $260 Million



5/26/2011 9:28:02 AM

Diagnostics company bioMerieux (PARIS:BIM) is acquiring French microbiological analysis company AES Laboratoire for $260 million.

France-based bioMerieux, which has its U.S. headquarters in Durham, North Carolina, gains AES’ expertise in analyzing microbiological samples in industrial settings. The acquisition is bioMerieux’s ninth in five years.

BioMerieux’s strength is in medical diagnostics and some of the company’s recent acquisitions have reflected the company’s effort to boost its capabilities in that area. For example, in 2008, bioMerieux gained molecular diagnostics capabilities with its $60 million purchase of San Diego company AviaraDx, whose molecular testing technology is used for cancer diagnostics. BioMerieux is also in a partnership with pharmaceutical firm Ipsen (PARIS:IPN) to develop companion diagnostics for cancer, tests that help doctors make therapeutic decisions about how to treat patients and which drugs to use.


Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES